Cogent Biosciences, Inc. (COGT)
Largest Insider Buys in Sector
COGT Stock Price History Chart
COGT Stock Performance
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Cogent Biosciences, Inc.
Over the last 12 months, insiders at Cogent Biosciences, Inc. have bought $332,413 and sold $0 worth of Cogent Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Cogent Biosciences, Inc. have bought $6.61M and sold $473,103 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Pinnow Cole (Chief Commercial Officer) — $332,413.
The last purchase of 43,750 shares for transaction amount of $332,413 was made by Pinnow Cole (Chief Commercial Officer) on 2025‑01‑14.
List of Insider Buy and Sell Transactions, Cogent Biosciences, Inc.
| 2025-01-14 | Chief Commercial Officer | 43,750 0.0412% | $7.60 | $332,413 | +10.24% | |||
| 2023-06-09 | 10 percent owner | 800,000 0.9139% | $12.00 | $9.6M | -33.60% | |||
| 2022-06-16 | 1.2M 0.9424% | $8.25 | $9.9M | +55.51% | ||||
| 2021-04-26 | Sale | Chief Financial Officer | 17,813 0.015% | $8.86 | $157,823 | -6.66% | ||
| 2020-05-12 | Sale | 10 percent owner | 98,200 0.0043% | $0.46 | $45,545 | +429.08% | ||
| 2020-05-11 | Sale | 10 percent owner | 100,000 0.0043% | $0.46 | $45,496 | +440.83% | ||
| 2020-05-08 | Sale | 10 percent owner | 100,000 0.0044% | $0.46 | $46,390 | +433.33% | ||
| 2020-05-07 | Sale | 10 percent owner | 100,000 0.0039% | $0.41 | $41,430 | +482.93% | ||
| 2020-05-06 | Sale | 10 percent owner | 1,800 <0.0001% | $0.40 | $722 | +524.04% | ||
| 2020-05-05 | Sale | 10 percent owner | 135,484 0.0052% | $0.40 | $54,437 | +508.44% | ||
| 2020-05-04 | Sale | 10 percent owner | 4,795 0.0002% | $0.40 | $1,921 | +508.44% | ||
| 2020-05-01 | Sale | 10 percent owner | 800 <0.0001% | $0.41 | $328 | +506.21% | ||
| 2020-04-30 | Sale | 10 percent owner | 75,994 0.0029% | $0.40 | $30,557 | +465.99% | ||
| 2020-04-29 | Sale | 10 percent owner | 382,927 0.0148% | $0.41 | $155,507 | +508.44% | ||
| 2020-04-28 | Sale | 10 percent owner | 15,048 0.0006% | $0.41 | $6,168 | +479.46% | ||
| 2020-04-27 | Sale | 10 percent owner | 242,579 0.0093% | $0.40 | $97,808 | +508.44% | ||
| 2020-04-20 | Sale | 10 percent owner | 12,606 0.0005% | $0.40 | $5,050 | +524.04% | ||
| 2020-04-17 | Sale | 10 percent owner | 65,540 0.0024% | $0.39 | $25,574 | +525.64% | ||
| 2020-04-16 | Sale | 10 percent owner | 600 <0.0001% | $0.38 | $230 | +566.78% | ||
| 2020-04-15 | Sale | 10 percent owner | 82,782 0.003% | $0.38 | $31,797 | +549.00% |
Insider Historical Profitability
| Pinnow Cole | Chief Commercial Officer | 45848 0.0415% | $8.25 | 1 | 0 | |
| FROST PHILLIP MD ET AL | 15734874 14.2446% | $8.25 | 6 | 0 | ||
| Schulke Ryan | Chief Executive Officer | 6364537 5.7617% | $8.25 | 9 | 0 | +150.58% |
| Conlin Matthew | President | 4437980 4.0177% | $8.25 | 7 | 0 | +150.58% |
| Booth Bruce | director | 3361535 3.0432% | $8.25 | 1 | 0 | <0.0001% |
| Atlas Venture Fund IX, L.P. | 10 percent owner | 3361535 3.0432% | $8.25 | 1 | 0 | <0.0001% |
| Fairmount Funds Management LLC | 10 percent owner | 3272124 2.9622% | $8.25 | 2 | 0 | +10.96% |
| CAMPANA DARIO | 10 percent owner | 3095114 2.802% | $8.25 | 0 | 21 | |
| Ratcliffe Liam | director | 897773 0.8127% | $8.25 | 1 | 0 | <0.0001% |
| Dubner Derek | Chief Executive Officer | 589513 0.5337% | $8.25 | 4 | 3 | |
| FMR LLC | 452115 0.4093% | $8.25 | 1 | 0 | <0.0001% | |
| Reilly James Patrick | President | 379946 0.344% | $8.25 | 0 | 3 | |
| Fried Robert N | director | 337338 0.3054% | $8.25 | 1 | 0 | |
| Jordan Harry Baker III | Chief Operating Officer | 110000 0.0996% | $8.25 | 4 | 0 | |
| KIM PAUL | Chief Financial Officer | 50000 0.0453% | $8.25 | 0 | 13 | |
| Green John L. | Chief Financial Officer | 3841 0.0035% | $8.25 | 0 | 1 | |
| MacLachlan Daniel | Chief Financial Officer | 3500 0.0032% | $8.25 | 2 | 3 | |
| BOLGER JOHN C | director | 0 0% | $8.25 | 1 | 3 | |
| Hsieh Ming | Chief Executive Officer | 0 0% | $8.25 | 0 | 15 | |
| Ettenberg Seth | Chief Scientific Officer | 0 0% | $8.25 | 0 | 6 |